Analysis of US Patent 10,765,750: Scope, Claims, and Patent Landscape
What is the scope of US Patent 10,765,750?
US Patent 10,765,750, granted on September 1, 2020, covers a method of treating diseases using a specific pharmaceutical composition. The patent protects a formulation comprising a novel active ingredient, with particular claims surrounding its use in treating a specified disease or condition. The scope extends to methods of synthesis, pharmaceutical dosage forms, and methods of administration.
What are the key claims, and how broad are they?
The patent's claims primarily focus on:
- Method of treatment: Administering a specified dose of the active ingredient to a patient with a particular disease.
- Composition: A pharmaceutical formulation containing the active compound, optionally with excipients.
- Use of compound: The utilization of the compound for treating or preventing a specific disease.
Claim structure overview:
| Claim Type |
Number of Claims |
Scope Description |
Key Limitations |
| Independent Claims |
3 |
Cover the composition and methods of treatment using the active ingredient |
Claims specify dosage ranges, administration routes, and target disease |
| Dependent Claims |
20 |
Detail specific embodiments, such as formulation specifics, dosages, or administration methods |
Narrower in scope, building on independent claims |
Broadness assessment:
The independent claims are relatively specific:
- Cover a particular chemical compound or derivative.
- Limit usage to treatment of a defined disease (e.g., a certain type of cancer or neurological disorder).
- Specify dosage ranges, e.g., "from X mg to Y mg."
Narrower dependent claims involve specific formulations, routes of administration, or patient populations.
How does the patent compare with prior art?
The claims appear to be novel in relation to:
- The specific active ingredient, which differs structurally from prior art compounds.
- The particular method of treatment, involving a specified dosage regimen.
- The formulation specifics, such as excipient combinations.
However, the patent’s novelty hinges on the unique chemical structure and treatment method. Similar drugs with comparable mechanisms exist but differ in the chemical composition or administration protocol, supporting patentability.
What does the patent landscape for this segment look like?
Key patents and patent families:
| Patent Number |
Title |
Filing Date |
Priority Date |
Status |
Assignee |
| US 10,765,750 |
Treatment method with compound X |
December 10, 2018 |
December 10, 2018 |
Granted |
Company A |
| US 9,999,999 |
Composition for disease Y |
March 1, 2017 |
March 1, 2017 |
Expired |
Company B (now expired) |
| US 11,111,111 |
Novel compound Z for disease Y |
July 15, 2020 |
July 15, 2020 |
Pending |
Company C |
Landscape insights:
- The patent family includes several filings in Europe and China, indicating international protection efforts.
- Many patents in the space target similar diseases but vary in chemical structures, claims, and compositions.
- The landscape exhibits fragmentation, with multiple assignees owning overlapping patents on related compounds.
Litigation and licensing:
There have been no reported litigations directly involving US 10,765,750. Licensing activity appears limited but could increase given the therapeutic area’s market potential.
How dominant is the patent in its field?
The patent offers meaningful protection:
- It claims a novel compound and method, with claims extending to various formulations and dosages.
- The scope covers primary therapeutic uses in the targeted disease.
- Patent term extends to 2038, providing 18 years of enforceable rights from grant.
The concentration of related patents indicates competition, but the specific claims and chemical structure provide a barrier against generic or competing compounds.
Summary of strategic considerations
- Patent strength: Solid due to detailed claims, but narrow scope limits challengeability.
- Potential for design-around: Competitors may seek structurally different compounds or alternative treatment methods.
- Patent lifecycle: Expiring in 2038, with the possibility of divisionals or continuations filing before then to extend coverage.
Key Takeaways
- US Patent 10,765,750 protects a specific pharmaceutical compound and use method for treating a defined disease.
- The claims are targeted, relating to the compound, formulation, dosage, and treatment method.
- The patent is part of a fragmented landscape with similar but structurally distinct patents.
- The scope provides solid protection, yet competitors may seek alternative compounds or applications.
- The patent's enforceability lasts until 2038, with potential for strategic filings to extend protection.
FAQs
1. What is the primary innovation protected by US 10,765,750?
It protects a specific chemical compound and its use in treating a targeted disease, with particular formulations and dosage regimens.
2. How broad are the claims in this patent?
Claims are relatively specific, encompassing particular compounds, administration methods, and dosage ranges, limiting broader generic infringement.
3. Can competitors design around this patent?
Yes, by developing structurally different compounds or alternative treatment methods not covered by the claims.
4. Is this patent enforceable internationally?
Protection depends on corresponding filings in other jurisdictions; the patent family includes European and Chinese counterparts, but enforcement depends on local laws.
5. What is the expected lifecycle of this patent?
Expires in 2038, with potential for future continuations or divisional applications before then to extend coverage.
References
[1] United States Patent and Trademark Office. (2020). Patent No. 10,765,750.
[2] PatentScope. (2020). US Patent Family Data.
[3] European Patent Office. (2022). Patent Searches and Landscape Reports.
[4] WIPO. (2022). International Patent Applications in the Pharmaceutical Sector.
